Sharara, Ala I.
Alrazim, Ayman
Saniour, Philippe
Daniel, Fady
Rached, Antoine Abou
Bahr, Abbas
Azar, Cecilio
Geagea, Antoine
Ghoubar, Marcelle
Funding for this research was provided by:
Pfizer
Article History
Received: 18 December 2023
Accepted: 25 July 2024
First Online: 4 October 2024
Declarations
:
: Ethics approval for this study was granted by the Institutional Review Board (IRB) of the American University of Beirut (AUB). The need of consent was waived by IRB at AUB.
: Not applicable.
: Dr Ala Sharara is an employee at AUBMC which had received funding for the conduct of this study. Marcelle Ghoubar is a full-time Pfizer employee. Other authors have no conflict of interest to declare.